WebAug 29, 2024 · Results of this trial are different from other similar trials such as CABANA-AF, AFFIRM, and RACE. One difference is the population enrolled – recent onset (within 12 months) in EAST-AFNET 4 vs. more sustained AF in the other trials. There was also a reasonably high rate of AF ablation (8% at enrollment, 20% by 5 years) in the current trial. WebMay 10, 2024 · Shutterstock. Catheter ablation for atrial fibrillation (AF) produced no significant improvement in clinical outcomes in a large and important new clinical trial. CABANA is the first and long ...
Stroke and mortality risk after atrial fibrillation ablation: lesson ...
WebJul 1, 2024 · Abstract. The results of the CABANA trial were recently presented at the Heart Rhythm Society Meeting in May 2024, indicating that ablation in patients with atrial fibrillation (AF) did not confer ... WebOct 4, 2024 · Despite the CABANA (Cather Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation) trial trial results showing non-statistically significant decrease in mortality, stroke, bleeding, and cardiac arrest with catheter ablation versus antiarrhythmic therapy in the overall population, subgroup analysis of the study population showed … hop x reader oneshots
Evidence builds for AFib ablation’s efficacy in heart failure
WebJun 23, 2024 · More aggressive treatment of atrial fibrillation (AF) may not always lead to improved outcomes, particularly in patients with more advanced AF, according to results of the DECAAF II study.. A global study conducted at 44 centers in 10 countries, results of the study suggest a strategy of pulmonary vein isolation (PVI) plus MRI-guided atrial fibrosis … WebMay 10, 2015 · Dr. Lindsay: CABANA is a very interesting trial. It was one that really was designed to look at additional benefits from going through an ablation. What I mean by that is that most patients come to us for ablation procedures because they have symptomatic atrial fibrillation. Many of them, either medicines have failed to control their ... WebThe CABANA trial suggested that although ablation was better than drug to prevent AFib, there was no difference between drug and ablation for the primary end points and mortality. ... There is a question regarding the choice of using or not using interrupted or non-interrupted anticoagulation for atrial fibrillation ablation. The COMPARE trial ... look through subpart f